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CALENDAR
7-9 April 1997
Nuclear Oncology: From Genotype to Patient Care
Thomas B. Turner Building,Baltimore, Maryland
Sponsor:
Johns Hopkins University School of Medicine
Course director:
Henry N. Wagner Jr, MD
Nuclear medicine is the medical specialty best suited to translate
the exploding body of knowledge obtained from research in
genetics and molecular biology into the care of patients. This
fourth annual nuclear oncology conference will address how this
can be done and how positron emission tomography (PET) and
single photon emission tomography (SPECT) can detect the first
signs of disease in patients with increased genetic risk of devel-
oping cancer. The course will include illustrative patient studies,
showing how PET and SPECT can help diagnosis, staging and
treatment planning and monitoring.
The Johns Hopkins University School of Medicine is accredited
by the Accreditaion Council for Continuing Medical Education to
sponsor continuing medical education for physicians.
The Johns Hopkins University designates this continuing
medical education activity for up to 18 credit hours in Category 1
of the Physician's Recognition Award of the American Medical
Association.
Fee:
Physicians: $495; Residents, Fellows and Allied Health
Professionals: $395
Contactperson:
Program Coordinator, Johns Hopkins Medical Institutions, Office
ofContinuing Medical Education, Turner Building, 720 Rutland
Avenue, Baltimore, Maryland 21205
Tel: (410) 955 2959
Fax: (410) 955 0807
Internet: rturner@somr.admjhu.edu
or Julia W. Buchanan, Course Co-director,
Tel: (410) 955-8582
18-21 May 1997
4th Copenhagen Workshop on Carcinoma in situ and
Testicular Cancer Molecular and Endocrine Aspects
Copenhagen, Denmark
Further informationfrom:
Dr E Rajpert-De Meyts, Department ofGrowth and
Reproduction, The National University Hospital, 9 Blogdamavej,
2100 Copenhagen, Denmark. Tel: +45 35 45 55 15 Fax: +45 35
45 60 54 E-mail: erm@rh.dk
7-11 September 1997
International Congress on Chronobiology
Paris, France
Further informationfrom:
Pr Yvan Touitou, Conference President, Internaitonal Congress on
Chronobiology, Service de Biochimie Medicale, Faculte de
Medecine Pitie-Salpetrere, 91 boulevard de 1' Hopital, 75634
Paris Cedex 13, France. Tel: (+33-01) 40 77 96 63 Fax: (+33-01)
40 77 96 65 E-mail: touitou@ccrjussleu.fr
14-18 September 1997
The European Cancer Conference
Hamburg, Germany
Further informationfrom:
Luc Hendrickx, Conference and Finance Manager, ECCO 9
Secretariat, FBCS - Conference Unit, Avenue E Mounier 83,
B-1200 Brussels. Tel: +32 (2) 775 02 02 Fax: +32 (2) 775 02 00
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